Where does Venn Biosciences Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Venn Biosciences Corporation ranks #43,918 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Venn Biosciences Corporation hold?

Venn Biosciences Corporation holds 6 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is Venn Biosciences Corporation's Innovation Score?

Venn Biosciences Corporation has an Innovation Score of 45.5 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Venn Biosciences Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Venn Biosciences Corporation.

What does claim depth mean for Venn Biosciences Corporation's patents?

Venn Biosciences Corporation's patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Venn Biosciences Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Venn Biosciences Corporation

Q: What technology areas does Venn Biosciences Corporation focus on?

Venn Biosciences Corporation's top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 6 patents, ranking #116 of 676 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Venn ranks #43,918 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.

#43,918
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 19.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R43918 · US Corporation #43,918 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #43,918/49,997
PHOTO-FINISH Veil Intimates
CPC-NARROW G16B · 4 areas
INNOV-PAR 45.5/100
CLAIMS-RICH 19.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Veil Intimates LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Venn’s 45.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (15%) Velocity 20.0 pts (44%) Breadth 7.1 pts (16%) Claim depth 11.7 pts (26%)

Qualcomm Incorporated · highest

85
Venn Biosciences · this assignee

45
3D Lighting… · lowest

7

What this shows Venn's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Venn?

Each dot is one of Venn’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Venn’s own 19.5 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Venn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Venn's grants concentrate

Venn Biosciences Corporation is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Venn sits between Veil Intimates LLC and Veolia Environment VE.

Venn's three-year grant acceleration

Venn Biosciences Corporation shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Veil Intimates

6
Veloce Biopharma

6
Velocity Systems

6
Vengo

6
Venn Technology

6
Ventirx Pharmaceu…

6
Ventriflo

6
Veolia Environmen…

6
Venn Biosciences ◀

6

What this shows Venn holds 6 patents at rank #43,937, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Venn

By rank, the assignees closest to #43,937 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Venn's primary technology class.

Venn's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Venn Biosciences Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	16.7%
2023	2	33.3%
2024	2	33.3%
2025partial year	1	16.7%

Which technologies does Venn Biosciences Corporation patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G06N - Computing Arrangements Based ON Specific Computational Models 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Venn Biosciences Corporation's patent record in context - here's where to go next.

Venn Biosciences Corporation's lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 100% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #43,918 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Venn Biosciences Corporation against Veil Intimates LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.